MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Medtech in a Minute: FTC Blocks a Big Deal, Boston Scientific Scores a Win for Patient Safety, and More Image by OpenClipart-Vectors on Pixabay
Your time is valuable, so we've drilled down the three most important medtech stories from the past week. But feel free to click the headline to read beyond the blurb.

Medtech in a Minute: FTC Blocks a Big Deal, Boston Scientific Scores a Win for Patient Safety, and More

The duodenoscope market finally gets a fully disposable option and Tandem wins an important FDA clearance. But first, why did FTC halt a $1.2 billion medtech merger?

FTC Blocks Illumina-PacBio Deal

The Federal Trade Commission is challenging the $1.2 billion-merger between Illumina and PacificBio (PacBio). The agency says Illumina is seeking to unlawfully maintain its monopoly in the U.S. market for next-generation DNA sequencing systems by extinguishing PacBio as a nascent competitive threat.

Fully Disposable Duodenoscope Is a Win for Patient Safety

Boston Scientific snagged FDA clearance to sell its Exalt-D single-use duodenoscope in the United States to provide visualization and access to the upper gastrointestinal (GI) tract to treat bile duct disorders and other upper GI problems. The Exalt-D is the first fully disposable duodenoscope to reach the market, which is seen as a huge win for patient safety because contamination on duodenoscopes after reprocessing has been such a major concern.

Tandem's New FDA Clearance Strengthens Its Relationship with DexCom

Tandem Diabetes has won a major nod from FDA that has the potential to advance its partnership with DexCom. The company received clearance for the t:slim X2 insulin pump with Control-IQ technology, which integrates with DexCom's G6 continuous glucose monitoring (CGM) sensor. The pump uses the DexCom G6 CGM sensor values to forecast glucose levels and adjust insulin delivery to ensure the prevention of erratic highs and lows.

TAGS: News
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.